Objective: In order to assess the long-term (12 months) efficacy and safety of fenofibrate administered with simvastatin in the treatment of primary mixed hyperlipidaemia, we conducted a study that ...

ATLANTA – The addition of fenofibrate to simvastatin therapy failed to reduce the rate of fatal and nonfatal CV events in patients with diabetes, according to new results of the ACCORD Lipid Trial.

Fenofibrate 67mg, 134mg, 200mg; caps (micronized). Adjunct to diet: in severe hypertriglyceridemia; and to reduce elevated total-C, LDL-C, ApoB, and TG, and to increase HDL-C in primary hyperlipidemia ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. FENOFIBRATE VIATRIS contains the active ingredient fenofibrate.

The management of atherosclerotic cardiovascular disease (ASCVD) requires highly personalized lipid strategies, particularly ...

Use of the cholesterol-lowering drug fenofibrate had a modest but statistically significant association with reduced risk of vision-threatening diabetic retinopathy (VTDR), according to results of a ...

Please provide your email address to receive an email when new articles are posted on . Adults taking oral fenofibrate had a 27% reduction in diabetic eye disease progression over 4 years. Fenofibrate ...

OBJECTIVE: To investigate the effect of transcription-modulating drugs, fenofibrate and isotretinoin, on metabolic profile, insulin sensitivity of adipose and muscle tissues and gene expression in a ...

kidney cross section Researchers assessed the incidence and potential risk factors for the development of fenofibrate-associated nephrotoxicity in patients with gout. Fenofibrate-associated ...

The use of simvastatin combined with fibrates is generally thought to be potentially hazardous, unless the benefit of further improvement in lipid and lipoprotein levels in patients at high ...